What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis?

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1492-1494

  Yew, W W ^a   Chang, K C ^b   Chau, C H ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b Tuberculosis and Chest Service ^*  (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

ADULT; ANAMNESIS; CASE REPORT; HUMAN; LETTER; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ACETAMIDES; ADULT; DIABETES COMPLICATIONS; DRUG ADMINISTRATION SCHEDULE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; SMOKING; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 73249123564     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00111009     Document Type: Letter

References (5)

1. Migliori GB, Eker B, Richardson MD, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J 2009; 34: 387-393.
2. Park IN, Hong SB, Oh YM, et al. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother 2006; 58: 701-704.
3. Dietze R, Hadad DJ, McGee B, et al. Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis. Am J Respir Crit Care Med 2008; 178: 1180-1185.
4. Louie A, Heine HS, Kim K, et al. Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis. Antimicrob Agents Chemother 2008; 52: 2486-2496.
5. Rodriguez JC, Cebrián L, López M, et al. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. J Antimicrob Chemother 2004; 53: 441-444.